Light-Driven Method Turns Fluoroform, a Potent Greenhouse Gas, Into Pharmaceutical Building Blocks

Researchers at Hokkaido University have found a way to use light to break down fluoroform, a byproduct of Teflon manufacturing, and turn it into CF3 radicals for pharmaceutical synthesis. Fluoroform is cheap and has a global warming potential roughly 15,000 times that of CO2, so converting it into useful chemicals instead of venting or flaring it could cut emissions while creating value. The team used a ketone catalyst and a base to activate the gas under mild conditions, guided by computational predictions from the AFIR method. They added CF3 groups to alkenes, alkynes, aromatics, and complex bioactive molecules, and hit about 65 percent yield when making a pharma intermediate from methyl methacrylate. Nearly all of the catalyst could be recovered. The work is still at the lab stage, and scaling it would require understanding energy input, light efficiency, and continuous operation. But it shows a practical path to turn an underused industrial greenhouse gas into building blocks for drugs and materials.